Loading…
ENDRA Life Sciences Inc. is projected to rise to $7.96 by 2027, a +45% move from its current price of $5.49. NDRA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $5.08 | $5.49 | $5.92 | -0.06% |
| Jul 14 | $4.92 | $5.48 | $6.11 | -0.11% |
| Jul 15 | $4.80 | $5.48 | $6.26 | -0.17% |
| Jul 16 | $4.70 | $5.48 | $6.39 | -0.23% |
| Jul 17 | $4.61 | $5.47 | $6.50 | -0.29% |
| Jul 18 | $4.53 | $5.47 | $6.60 | -0.34% |
| Jul 19 | $4.46 | $5.47 | $6.70 | -0.40% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.46 | $5.47 | $6.70 | -0.40% |
| Week 2 | $4.09 | $5.45 | $7.26 | -0.80% |
| Week 3 | $3.82 | $5.42 | $7.71 | -1.20% |
| Week 4 | $3.60 | $5.40 | $8.11 | -1.60% |
| Week 5 | $3.42 | $5.38 | $8.47 | -1.99% |
| Week 6 | $3.26 | $5.36 | $8.81 | -2.38% |
| Week 7 | $3.12 | $5.34 | $9.13 | -2.78% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ENDRA Life Sciences Inc. (NDRA) is a healthcare company focused on improving clinical diagnostic ultrasound capabilities. The company develops thermo-acoustic enhanced ultrasound technology that uses pulsed energy sources such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images.
These capabilities support applications in non-alcoholic fatty liver disease, tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis.
ENDRA Life Sciences was incorporated in 2007 and is based in Ann Arbor, Michigan. The company operates within the healthcare sector.
ENDRA Life Sciences Inc. operates in the healthcare sector. The current price is $5.49 and the market capitalization is $6.97M. The stock is ranked 5238. The near-term price outlook is shaped by technical factors with a 30-day price range of $3.26 to $9.23 and a bullish tilt in sentiment; key levels include RSI 14 at 60, SMA50 at $5.03, SMA200 at $4.93, with support at $4.19 and resistance at $6.27.
The stock exhibits notable volatility, reflecting an annualized volatility of 200%.
A major floor 40.6% below — a decisive break under it would weaken the trend.
The nearest floor, 23.7% below — buyers have tended to step in here.
The nearest ceiling, 14.2% above — a clean break opens room to run.
A major ceiling 35.5% above — clearing it would confirm fresh momentum.
Key NDRA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NDRA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.12 | Buy | $5.25 | Buy |
| MA 10 | $5.07 | Buy | $5.13 | Buy |
| MA 20 | $5.00 | Buy | $5.05 | Buy |
| MA 50 | $5.06 | Buy | $4.97 | Buy |
| MA 100 | $4.66 | Buy | $4.91 | Buy |
| MA 200 | $4.94 | Buy | $15.48 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.48 | Neutral |
| Stoch RSI (14) | 54.84 | Neutral |
| CCI (20) | 125.78 | Buy |
| Williams %R (14) | -33.50 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | 5.65 | Buy |
| Bollinger %B (20,2) | 0.85 | Neutral |
| Stochastic %K (14) | 66.50 | Neutral |
| TRIX (15) | 0.01 | Buy |
| Awesome (5,34) | 0.13 | Buy |
| Ultimate (7,14,28) | 56.24 | Neutral |
| Momentum (10) | 1.31 | Buy |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 5.29 | Buy |
| ADX (14) | 9.29 | Neutral |
| ATR (14) | 0.34 | Info |
The near-term technical picture remains bullish. RSI(14) sits around 60, supporting a constructive posture. The 50-day simple moving average is at $5.03 and the 200-day simple moving average at $4.93, indicating ongoing upward momentum relative to longer-term trends.
Nearby support stands at $4.19 and resistance at $6.27, with the 30-day trading range spanning $3.26 to $9.23.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.26 | $5.49 | $7.18 | 0% | Neutral | |
| $5.78 | $7.96 | $11.87 | +45% | Bullish | |
| $6.23 | $9.12 | $14.48 | +66% | Bullish | |
| $5.67 | $8.75 | $14.60 | +59% | Bullish | |
| $5.69 | $9.20 | $15.96 | +68% | Bullish | |
| $4.48 | $7.58 | $13.62 | +38% | Bullish | |
| $4.55 | $8.03 | $14.88 | +46% | Bullish | |
| $6.64 | $12.20 | $23.22 | +122% | Bullish | |
| $7.05 | $13.48 | $26.31 | +145% | Bullish | |
| $6.49 | $12.89 | $25.75 | +135% | Bullish | |
| $8.75 | $19.44 | $42.67 | +254% | Bullish | |
| $11.20 | $24.88 | $57.22 | +353% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.26 | $5.49 | $6.88 | +0.00% |
| August 2026 | $4.38 | $5.31 | $6.70 | -3.27% |
| September 2026 | $4.24 | $5.21 | $6.71 | -1.90% |
| October 2026 | $4.58 | $5.70 | $7.47 | +9.40% |
| November 2026 | $4.60 | $5.78 | $7.68 | +1.35% |
| December 2026 | $4.20 | $5.33 | $7.18 | -7.72% |
Click any year to see its month-by-month NDRA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
ENDRA Life Sciences Inc.'s 2026 outlook centres on $5.49, within a $3.26 to $7.18 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, NDRA could reach as high as $11.87, with a base case around $7.96 and support toward $5.78 — roughly +45% from $5.49. Buyers look set to stay in control over this stretch.
Expect NDRA to range from $6.23 to $14.48 through 2028. The $9.12 average target implies a +66% move from current prices. That is up +15% on the projected 2027 average. Momentum favours further upside here.
The NDRA price prediction for 2029 points to an average of $8.75 (low $5.67, high $14.60) — a potential gain of +59% on today's $5.49. Buyers look set to stay in control over this stretch.
In 2030, NDRA is projected to trade between $5.69 and $15.96, averaging $9.20 — a potential gain of +68% from today's $5.49. That is up +5% on the projected 2029 average. Momentum favours further upside here.
ENDRA Life Sciences Inc.'s 2031 outlook centres on $7.58, within a $4.48 to $13.62 range. That is -18% versus the projected 2030 average. That marks a +38% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, NDRA could reach as high as $14.88, with a base case around $8.03 and support toward $4.55 — roughly +46% from $5.49. Momentum favours further upside here.
Expect NDRA to range from $6.64 to $23.22 through 2033. The $12.20 average target implies a +122% move from current prices. That is up +52% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The NDRA price prediction for 2034 points to an average of $13.48 (low $7.05, high $26.31) — a potential gain of +145% on today's $5.49. Momentum favours further upside here.
In 2035, NDRA is projected to trade between $6.49 and $25.75, averaging $12.89 — a potential gain of +135% from today's $5.49. That is -4% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
ENDRA Life Sciences Inc.'s 2040 outlook centres on $19.44, within a $8.75 to $42.67 range. That is up +51% on the projected 2035 average. That marks a +254% change versus current levels. Momentum favours further upside here.
By 2050, NDRA could reach as high as $57.22, with a base case around $24.88 and support toward $11.20 — roughly +353% from $5.49. Buyers look set to stay in control over this stretch.
Investing $1,000 in NDRA today (≈ 182.149362 NDRA) could be worth
$4,531.69
+$3,531.69 (+353%) by 2050 · US Dollar
Based on the average projected NDRA price of $24.88 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NDRAwould be worth at today's price.
$1,000 invested in NDRA on Jul 10, 2025 (≈ 125 NDRA) would be worth
$686.25
-$313.75 (-31.4%) today · 0.69× · US Dollar
Based on a NDRA entry price of $8 vs. today's $5.49.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.72 | $1,163.14 | +16.3% |
| 1 month ago | $4.19 | $1,310.26 | +31.0% |
| 3 months ago | $4.94 | $1,111.34 | +11.1% |
| 6 months ago | $4.51 | $1,217.29 | +21.7% |
| 1 year ago | $8 | $686.25 | -31.4% |
| All time (5.0y) ago | $68,250 | $0.08 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NDRA forecast.
Our base-case forecast reaches $11.00 around 2033.
Implied market cap at $11.00: $13.97M
The multi-year forecast shows sustained bullish sentiment across multiple years. In 2026 the average price is $5.49 with a neutral outlook; by 2027 the average price rises to $7.78 and the max to $11.60 under a bullish stance. The forecast continues higher in 2028 with an average of $8.95 and a max of $14.22, and in 2029 an average of $8.58 with a max of $14.31.
By 2030 the average is $9.00, max $15.62, with a bullish sentiment and a 63.9% ROI. In 2033 the average climbs to $11.59 and the max to $22.07 (ROI 111.1%), and by 2034 the average reaches $12.86 with a max of $25.11 (ROI 134.3%). The 2040 forecast shows an average of $18.31 and a max of $40.20 (ROI 233.6%), while the 2050 forecast projects an average of $22.82 and a max of $52.49 (ROI 315.7%).
These projections assume bullish momentum but are not guarantees, and actual results may differ.
Tap a question to reveal the answer.
The forecast shows an average price of $9.00 with a range from $5.56 to $15.62 and a 63.9% ROI; sentiment is BULLISH.
The long-range forecast is BULLISH with an average price of $22.82 by 2050 and a potential ROI of 315.7%. Near-term the 2026 forecast is neutral, with bullish momentum developing in 2027 and beyond.
Yes. The 2050 maximum forecast is $52.49, indicating a potential to reach or exceed $50 under the modeled scenario.
Current price is $5.49 and market capitalization is $6.97M.
The 30-day range is $3.26 to $9.23 with RSI(14) at 60. Support is at $4.19 and resistance at $6.27.
ENDRA Life Sciences Inc. Community Discussion
0Share your ENDRA Life Sciences Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.